Persistent androgen receptor (AR) transcriptional activity underlies resistance to AR-targeted
therapy and progression to lethal castration-resistant prostate cancer (CRPC). Recent …

Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau
tumour suppressor gene (VHL) 1 , 2 . Because no other gene is mutated as frequently …

The introduction of insertion-deletions (INDELs) by non-homologous end-joining (NHEJ)
pathway underlies the mechanistic basis of CRISPR-Cas9-directed genome editing. Selective …

Reactivation of the androgen receptor (AR) during androgen depletion therapy (ADT) underlies
castration-resistant prostate cancer (CRPCa). Alternative splicing of the AR gene and …

The use of lithium metal either in an anode or anode-free configuration is envisaged as the
most promising way to boost the energy density of the current lithium-ion battery system. …

ARID1A, an SWI/SNF chromatin-remodeling gene, is commonly mutated in cancer and
hypothesized to be tumor suppressive. In some hepatocellular carcinoma patients, ARID1A was …

Genomic profiling can provide prognostic and predictive information to guide clinical care.
Biomarkers that reliably predict patient response to chemotherapy and immune checkpoint …

Androgen receptor (AR) target genes direct development and survival of the prostate epithelial
lineage, including prostate cancer (PCa). Thus, endocrine therapies that inhibit the AR …

Sexual dimorphism at the level of MDSC subset prevalence, localization, and gene-expression
profile constitutes a therapeutic opportunity. Our results indicate that chemotherapy can …

Brain tumor initiating cells (BTICs), also known as cancer stem cells, hijack high-affinity glucose
uptake active normally in neurons to maintain energy demands. Here we link metabolic …